Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Verheyen

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
BMC Bioinformatics|January 22, 2010
Predicting Bevirimat resistance of HIV-1 from genotypeDominik Heider, Jens Verheyen, Daniel Hoffmann
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2021
Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed PatientBenedikt Lohr, Dirk Niemann, Jens Verheyen
BMC Research Notes|April 2, 2011
Machine learning on normalized protein sequencesDominik Heider, Jens Verheyen, Daniel Hoffmann
The New England Journal of Medicine|December 18, 2014
More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutationJens Verheyen, Stefan Esser, Lambros Kordelas
Visceral Medicine|July 15, 2016
Liver Failure due to Acute Viral Hepatitis (A-E)Paul Manka, Jens Verheyen, Guido Gerken, et al.
Journal of Clinical Microbiology|October 2, 2009
Seasonal influenza virus species in patient swab samples analyzed for the presence of the pandemic (H1N1) 2009 influenza virusJens Verheyen, Melanie Balduin, Rolf Kaiser, et al.
Retrovirology|August 8, 2012
Human Immunodeficiency Virus Gag and protease: partners in resistanceAxel Fun, Annemarie M J Wensing, Jens Verheyen, et al.
Viral Immunology|April 2, 2016
Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T CellsJara J Joedicke, Miriam Dirks, Stefan Esser, et al.
Plos One|December 31, 2013
Inferring short-range linkage information from sequencing chromatogramsBastian Beggel, Maria Neumann-Fraune, Rolf Kaiser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2012
The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assaysJens Verheyen, Maria Neumann-Fraune, Thomas Berg, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
BMC Bioinformatics|January 22, 2010
Predicting Bevirimat resistance of HIV-1 from genotypeDominik Heider, Jens Verheyen, Daniel Hoffmann
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2021
Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed PatientBenedikt Lohr, Dirk Niemann, Jens Verheyen
BMC Research Notes|April 2, 2011
Machine learning on normalized protein sequencesDominik Heider, Jens Verheyen, Daniel Hoffmann
The New England Journal of Medicine|December 18, 2014
More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32/delta32 mutationJens Verheyen, Stefan Esser, Lambros Kordelas
Visceral Medicine|July 15, 2016
Liver Failure due to Acute Viral Hepatitis (A-E)Paul Manka, Jens Verheyen, Guido Gerken, et al.
Journal of Clinical Microbiology|October 2, 2009
Seasonal influenza virus species in patient swab samples analyzed for the presence of the pandemic (H1N1) 2009 influenza virusJens Verheyen, Melanie Balduin, Rolf Kaiser, et al.
Retrovirology|August 8, 2012
Human Immunodeficiency Virus Gag and protease: partners in resistanceAxel Fun, Annemarie M J Wensing, Jens Verheyen, et al.
Viral Immunology|April 2, 2016
Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T CellsJara J Joedicke, Miriam Dirks, Stefan Esser, et al.
Plos One|December 31, 2013
Inferring short-range linkage information from sequencing chromatogramsBastian Beggel, Maria Neumann-Fraune, Rolf Kaiser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2012
The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assaysJens Verheyen, Maria Neumann-Fraune, Thomas Berg, et al.
Pageof 7